MedPath

AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma

Not Applicable
Active, not recruiting
Conditions
Asthma
Registration Number
NCT04448002
Lead Sponsor
University of Florida
Brief Summary

The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
320
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Asthma Control using asthma control questionnaireChange in baseline, post-intervention,3 months, and 6 months, and 12 month follow-up

Measured via the Asthma Control Test questionnaire which has 5 items that assesses frequency of daytime and nocturnal asthma symptoms, activity limitations, and perceptions of disease control.Adolescents will complete all 5 items independently of caregivers. Scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score \>19 indicates well-controlled asthma."

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

UF Health Pediatrics

🇺🇸

Gainesville, Florida, United States

Nemours Children's Hospital

🇺🇸

Jacksonville, Florida, United States

UF Health Pediatrics
🇺🇸Gainesville, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.